Genesis BioCapital Fund I, LP
Amendment
CIK: 0002053141·Pooled Investment Fund·DELAWARE·Filed: Jan 23, 2026
Total Offering
N/A
Amount Sold
$18,480,000
Investors
21
First Sale
Jan 24, 2025
Offering Details
- Type
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(7)
Related Persons
| Name | Role |
|---|---|
| Genesis BioCapital Fund I GP, LP | Executive Officer |
| Genesis BioCapital Management, LLC | Executive Officer |
| Ray Tabibiazar | Executive Officer |
Company
SEC Filing
0001493152-26-003327
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free